Haseena Sophia Mooncey’s Post

I’d love to say my trip to NYC earlier this year had a part to play in the UK-US deal around Pharma exports being tariff-free for three years, but I’m unsure I had any influence 😂 While UK exports will benefit, a potential £3billion rise in NHS drug spend is expected. Is this deal enough to keep the UK attractive and make us more competitive, or is it simply increasing domestic costs whilst investment shifts to the US? https://lnkd.in/e4xEMShj